Alterity Therapeutics commences US investor meetings following positive clinical data May 13, 2019August 16, 2022
Further Information – Prana’s PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective July 17, 2013August 16, 2022
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy January 9, 2023January 9, 2023
